Allergies News and Research

Latest Allergies News and Research

Article shows link between maternal cigarette smoking during pregnancy, SIDS

The link between maternal cigarette smoking during pregnancy and Sudden Infant Death Syndrome may relate to the negative effects of nicotine on the development of brain centers that regulate breathing, according to an article in the recent issue of Pediatric Allergy, Immunology, and Pulmonology, a peer-reviewed journal published by Mary Ann Liebert, Inc.

10 Nov 2010

Popular antimicrobial chemicals may not be safe for human health and environment

Killing microorganisms has become a national obsession. A pair of antimicrobial compounds known as triclosan and triclocarban are lately the weapons of choice in our war of attrition against the microbial world. Both chemicals are found in an array of personal care products like antimicrobial soaps, and triclosan also is formulated into everyday items ranging from plastics and toys to articles of clothing.

10 Nov 2010

IMNG partners with Pure Incubation to launch new product resource guide

International Medical News Group, LLC, an Elsevier company that provides medical news and information to physicians, announced today the launch of Cardiology Product Zone. This new product resource guide is launched in partnership with Pure Incubation, a company that specializes in developing data driven web properties and performance media programs that are focused exclusively on the product buying process.

10 Nov 2010

Miriam Hospital receives NIH grants to improve HIV treatment for jail inmates

The Miriam Hospital received three of the 12 newly awarded grants from the National Institutes of Health (NIH) aimed at improving HIV prevention and treatment of prison and jail inmates.

10 Nov 2010

Orexo third quarter net revenues decrease to MSEK 35.9

"During the third quarter, Abstral™ sales were 480% higher than in the same period last year. Sales of Edluar™, Orexo's sublingual zolpidem treatment for insomnia, continue to grow more strongly from a low base, with new stock being ordered for the first time since launch and generating royalty income for Orexo.

10 Nov 2010

EUSA completes BLA filing for ERWINASE in treatment of acute lymphoblastic leukemia

EUSA Pharma, a transatlantic specialty pharmaceutical company focused on oncology, oncology supportive care and critical care, today announced that it has submitted a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for ERWINASE(R) (L-asparaginase derived from Erwinia chrysanthemi) for use in the treatment of acute lymphoblastic leukemia in patients with hypersensitivity to E. coli-derived asparaginase.

9 Nov 2010

Researchers examine burden of HIV and sexually transmitted diseases in China

A new study by researchers at the Johns Hopkins Bloomberg School of Public Health examines the burden of HIV and sexually transmitted disease among male clients of the commercial sex industry in China's Sichuan province

9 Nov 2010

NEW ANA testing does not diagnose disorder in 40% of scleroderma patients

New research from Georgetown University Medical Center (GUMC) suggests that up to 40 percent of scleroderma patients will not be correctly diagnosed with the disorder using a new automated commercial screening test. The findings of the study will be presented Wednesday, November 10th at the Annual Scientific Meeting of the American College of Rheumatology in Atlanta, Georgia.

9 Nov 2010

Joint complaints attributed to breast cancer drugs not linked with inflammatory arthritis or autoimmune disease

A new study suggests joint complaints attributed to aromatase inhibitors (AI), popular breast cancer drugs, are not associated with inflammatory arthritis or autoimmune disease. Because of that, researchers say women who were primarily concerned about the threat of arthritis should be encouraged to continue taking the medication. The findings of the study will be presented Tuesday, Nov. 9 at the 74th Annual Scientific Meeting of the American College of Rheumatology in Atlanta, Georgia

9 Nov 2010

Scientists develop nanobioconjugate drug to target brain tumor

Nine years ago, scientists at Cedars-Sinai's Maxine Dunitz Neurosurgical Institute detected a subtle shift occurring in the molecular makeup of the most aggressive type of brain tumors, glioblastoma multiforme. With further study, they found that a specific protein called laminin-411 plays a major role in a tumor's ability to build new blood vessels to support its growth and spread. But technology did not exist then to block this protein.

9 Nov 2010

NUVO announces positive results from WF10 Phase 2 clinical trial for severe allergic rhinitis

Nuvo Research Inc. a specialty pharmaceutical company focused on the research and development of drug products that are delivered into and through the skin using its topical and transdermal drug delivery technologies and on the development of its immune modulating drug candidate WF10, today announced that its European Phase 2 clinical trial evaluating WF10 as a treatment for severe allergic rhinitis met its primary endpoint.

8 Nov 2010

Maternal peanut consumption during pregnancy increases peanut allergy risk in children

Babies born to mothers who eat peanuts during pregnancy appear more prone to peanut allergy, according to research conducted by scientists at Johns Hopkins Children's Center and elsewhere and published online in the Journal of Allergy and Clinical Immunology. The research team was led by Scott Sicherer, M.D., of the Mount Sinai School of Medicine in New York.

8 Nov 2010

bitop includes first patient in Ectoin inhalation solution clinical trial for inflammation and airway obstruction

bitop AG, a biotech company specializing in the development of Ectoin®-containing medical devices, announced the inclusion of the first patient into a clinical trial on the Ectoin inhalation solution in patients with inflammation and airway obstruction.

8 Nov 2010

UC researchers receive four-year grant to study mechanism of malarial parasite replication in RBCs

Today, about half the world's population lives in areas at risk of malaria transmission. The disease is transmitted to humans through bites from mosquitoes, and each year causes hundreds of thousands of deaths worldwide, with about 1,500 of these in the United States.

8 Nov 2010

Rcopia-MU certified as EHR Module by CCHIT

DrFirst announced today that Rcopia-MU, Version 3, is 2011/2012 compliant and was certified as an EHR Module on November 4, 2010, by the Certification Commission for Health Information Technology (CCHIT), an ONC-ATCB, in accordance with the applicable eligible provider certification criteria adopted by the Secretary of Health and Human Services.

8 Nov 2010

FDA approves Cymbalta for treatment of chronic musculoskeletal pain

The U.S. Food and Drug Administration today approved Cymbalta (duloxetine hydrochloride) to treat chronic musculoskeletal pain, including discomfort from osteoarthritis and chronic lower back pain. Cymbalta was first used to treat major depressive disorder in 2004.

8 Nov 2010

Prestige Brands second fiscal quarter net revenue decreases 3% to $78.3 million

Prestige Brands Holdings, Inc. today announced results for the second quarter and first half of fiscal year 2011, which ended on September 30, 2010. The Company also announced the completion on November 1, 2010 of the acquisition of Blacksmith Brands, Inc., which added five over-the-counter healthcare products to its business.

4 Nov 2010

QLT third quarter sales decreases 12.9% to $20.5 million

QLT Inc. today reported financial results for the third quarter ended September 30, 2010. Unless specified otherwise, all amounts are in U.S. dollars and in accordance with U.S. GAAP.

3 Nov 2010

Scientists recommend research on bacterial vaccine to prevent influenza

Secondary infections with bacteria such as Streptococcus pneumoniae, which causes pneumonia, were a major cause of death during the 1918 flu pandemic and may be important in modern pandemics as well, according to a new article in the Journal of Infectious Diseases co-authored by David M. Morens, M.D., senior advisor to the director of the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health.

3 Nov 2010

ISTA third quarter net revenue increases 31% to $42.0 million

ISTA Pharmaceuticals, Inc. today reported financial results for the quarter ended September 30, 2010. Third quarter 2010 net revenues were $42.0 million, an increase of 31% from the third quarter of 2009.

3 Nov 2010

Allergies News and Research

Latest Allergies News and Research

Article shows link between maternal cigarette smoking during pregnancy, SIDS

Popular antimicrobial chemicals may not be safe for human health and environment

IMNG partners with Pure Incubation to launch new product resource guide

Miriam Hospital receives NIH grants to improve HIV treatment for jail inmates

Orexo third quarter net revenues decrease to MSEK 35.9

EUSA completes BLA filing for ERWINASE in treatment of acute lymphoblastic leukemia

Researchers examine burden of HIV and sexually transmitted diseases in China

NEW ANA testing does not diagnose disorder in 40% of scleroderma patients

Joint complaints attributed to breast cancer drugs not linked with inflammatory arthritis or autoimmune disease

Scientists develop nanobioconjugate drug to target brain tumor

NUVO announces positive results from WF10 Phase 2 clinical trial for severe allergic rhinitis

Maternal peanut consumption during pregnancy increases peanut allergy risk in children

bitop includes first patient in Ectoin inhalation solution clinical trial for inflammation and airway obstruction

UC researchers receive four-year grant to study mechanism of malarial parasite replication in RBCs

Rcopia-MU certified as EHR Module by CCHIT

FDA approves Cymbalta for treatment of chronic musculoskeletal pain

Prestige Brands second fiscal quarter net revenue decreases 3% to $78.3 million

QLT third quarter sales decreases 12.9% to $20.5 million

Scientists recommend research on bacterial vaccine to prevent influenza

ISTA third quarter net revenue increases 31% to $42.0 million

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Allergies News and Research

Latest Allergies News and Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Newsletters you may be interested in